Veracyte's total assets for Q2 2026 were $1.49B, an increase of 3.48% from the previous quarter. DE:12V total liabilities were $97.96M for the fiscal quarter, a 6.49% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.